"The
Report Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, Opioid-Induced
Constipation (OIC)
- Pipeline Review, H2 2016, provides an overview of the
Opioid-Induced Constipation (OIC) pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Opioid-Induced Constipation (OIC), complete with
analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report
also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for
Opioid-Induced Constipation (OIC) and features dormant and
discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Opioid-Induced Constipation (OIC)
-
The report reviews pipeline therapeutics for Opioid-Induced
Constipation (OIC) by companies and universities/research institutes
based on information derived from
company
and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Opioid-Induced Constipation
(OIC) therapeutics and enlists all their major and minor projects
-
The report assesses Opioid-Induced Constipation (OIC) therapeutics
based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Opioid-Induced Constipation (OIC)
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Opioid-Induced Constipation (OIC)
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Opioid-Induced Constipation (OIC) pipeline depth and focus of
Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Table of Contents
Table
of Contents 2
List
of Tables 5
List
of Figures 5
Introduction
6
Global
Markets Direct Report Coverage 6
Opioid-Induced
Constipation (OIC) Overview 7
Therapeutics
Development 8
Pipeline
Products for Opioid-Induced Constipation (OIC) - Overview 8
Pipeline
Products for Opioid-Induced Constipation (OIC) - Comparative Analysis
9
Opioid-Induced
Constipation (OIC) - Therapeutics under Development by Companies 10
Opioid-Induced
Constipation (OIC) - Therapeutics under Investigation by
Universities/Institutes 11
Opioid-Induced
Constipation (OIC) - Pipeline Products Glance 12
Late
Stage Products 12
Clinical
Stage Products 13
Early
Stage Products 14
Opioid-Induced
Constipation (OIC) - Products under Development by Companies 15
Opioid-Induced
Constipation (OIC) - Products under Investigation by
Universities/Institutes 16
Opioid-Induced
Constipation (OIC) - Companies Involved in Therapeutics Development
17
Develco
Pharma Schweiz AG 17
Ironwood
Pharmaceuticals, Inc. 18
Shionogi
& Co., Ltd. 19
Sucampo
Pharmaceuticals, Inc. 20
Synergy
Pharmaceuticals, Inc. 21
Theravance
Biopharma, Inc. 22
Valeant
Pharmaceuticals International, Inc. 23
Opioid-Induced
Constipation (OIC) - Therapeutics Assessment 24
Assessment
by Monotherapy Products 24
Assessment
by Combination Products 25
Assessment
by Target 26
Assessment
by Mechanism of Action 28
Assessment
by Route of Administration 30
Assessment
by Molecule Type 32
Drug
Profiles 34
(axelopran
sulfate + oxycodone hydrochloride) - Drug Profile 34
Product
Description 34
Mechanism
Of Action 34
R&D
Progress 34
axelopran
sulfate - Drug Profile 35
Product
Description 35
Mechanism
Of Action 35
R&D
Progress 35
dolcanatide
- Drug Profile 37
Product
Description 37
Mechanism
Of Action 37
R&D
Progress 37
linaclotide
- Drug Profile 40
Product
Description 40
Mechanism
Of Action 40
R&D
Progress 40
lubiprostone
- Drug Profile 47
Product
Description 47
Mechanism
Of Action 47
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment